Endometriosis Treatment Market Size, Share Report, Analysis, Trends, Growth, 2030
Endometriosis Treatment Market By Drug Class (Oral Contraceptive, NSAIDs, Gonadotropin Releasing Hormones, and Others), By Treatment Type (Hormone Therapy and Pain Medication), By Route of Administration (Injectable, Oral, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 - 2030
Category: Pharmaceutical Report Format : PDF
Pages: 203 Report Code: ZMR-1858
Published Date: Mar-2023 Status : Published
| Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 1.3 Billion | USD 3.21 Billion | 13.51% | 2022 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Endometriosis Treatment Market, (2023 - 2023) (USD Billion)
- 2.2 Global Endometriosis Treatment Market : snapshot
- Chapter 3. Global Endometriosis Treatment Market - Industry Analysis
- 3.1 Endometriosis Treatment Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Growing prevalence of the medical condition to drive market demand
- 3.3 Market Restraints
- 3.3.1. Absence of a cure to restrict the market growth
- 3.4 Market Opportunities
- 3.4.1. Growing investment toward higher research to provide further opportunities
- 3.5 Market Challenges
- 3.5.1. High cost associated with the treatment to challenge market growth
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Drug Class
- 3.7.2 Market attractiveness analysis By Treatment Type
- 3.7.3 Market attractiveness analysis By Route of Administration
- Chapter 4. Global Endometriosis Treatment Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Endometriosis Treatment Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Endometriosis Treatment Market - Drug Class Analysis
- 5.1 Global Endometriosis Treatment Market overview: By Drug Class
- 5.1.1 Global Endometriosis Treatment Market share, By Drug Class, 2022 and 2023
- 5.2 Oral Contraceptive
- 5.2.1 Global Endometriosis Treatment Market by Oral Contraceptive, 2023 - 2023 (USD Billion)
- 5.3 NSAIDs
- 5.3.1 Global Endometriosis Treatment Market by NSAIDs, 2023 - 2023 (USD Billion)
- 5.4 Gonadotropin Releasing Hormones
- 5.4.1 Global Endometriosis Treatment Market by Gonadotropin Releasing Hormones, 2023 - 2023 (USD Billion)
- 5.5 Others
- 5.5.1 Global Endometriosis Treatment Market by Others, 2023 - 2023 (USD Billion)
- 5.1 Global Endometriosis Treatment Market overview: By Drug Class
- Chapter 6. Global Endometriosis Treatment Market - Treatment Type Analysis
- 6.1 Global Endometriosis Treatment Market overview: By Treatment Type
- 6.1.1 Global Endometriosis Treatment Market share, By Treatment Type, 2022 and 2023
- 6.2 Hormone Therapy
- 6.2.1 Global Endometriosis Treatment Market by Hormone Therapy, 2023 - 2023 (USD Billion)
- 6.3 Pain Medication
- 6.3.1 Global Endometriosis Treatment Market by Pain Medication, 2023 - 2023 (USD Billion)
- 6.1 Global Endometriosis Treatment Market overview: By Treatment Type
- Chapter 7. Global Endometriosis Treatment Market - Route of Administration Analysis
- 7.1 Global Endometriosis Treatment Market overview: By Route of Administration
- 7.1.1 Global Endometriosis Treatment Market share, By Route of Administration, 2022 and 2023
- 7.2 Injectable
- 7.2.1 Global Endometriosis Treatment Market by Injectable, 2023 - 2023 (USD Billion)
- 7.3 Oral
- 7.3.1 Global Endometriosis Treatment Market by Oral, 2023 - 2023 (USD Billion)
- 7.4 Others
- 7.4.1 Global Endometriosis Treatment Market by Others, 2023 - 2023 (USD Billion)
- 7.1 Global Endometriosis Treatment Market overview: By Route of Administration
- Chapter 8. Endometriosis Treatment Market - Regional Analysis
- 8.1 Global Endometriosis Treatment Market Regional Overview
- 8.2 Global Endometriosis Treatment Market Share, by Region, 2022 & 2023 (USD Billion)
- 8.3. North America
- 8.3.1 North America Endometriosis Treatment Market, 2023 - 2023 (USD Billion)
- 8.3.1.1 North America Endometriosis Treatment Market, by Country, 2023 - 2023 (USD Billion)
- 8.3.1 North America Endometriosis Treatment Market, 2023 - 2023 (USD Billion)
- 8.4 North America Endometriosis Treatment Market, by Drug Class, 2023 - 2023
- 8.4.1 North America Endometriosis Treatment Market, by Drug Class, 2023 - 2023 (USD Billion)
- 8.5 North America Endometriosis Treatment Market, by Treatment Type, 2023 - 2023
- 8.5.1 North America Endometriosis Treatment Market, by Treatment Type, 2023 - 2023 (USD Billion)
- 8.6 North America Endometriosis Treatment Market, by Route of Administration, 2023 - 2023
- 8.6.1 North America Endometriosis Treatment Market, by Route of Administration, 2023 - 2023 (USD Billion)
- 8.4. Europe
- 8.4.2 Europe Endometriosis Treatment Market, 2023 - 2023 (USD Billion)
- 8.4.2.1 Europe Endometriosis Treatment Market, by Country, 2023 - 2023 (USD Billion)
- 8.4.2 Europe Endometriosis Treatment Market, 2023 - 2023 (USD Billion)
- 8.4 Europe Endometriosis Treatment Market, by Drug Class, 2023 - 2023
- 8.4.1 Europe Endometriosis Treatment Market, by Drug Class, 2023 - 2023 (USD Billion)
- 8.5 Europe Endometriosis Treatment Market, by Treatment Type, 2023 - 2023
- 8.5.1 Europe Endometriosis Treatment Market, by Treatment Type, 2023 - 2023 (USD Billion)
- 8.6 Europe Endometriosis Treatment Market, by Route of Administration, 2023 - 2023
- 8.6.1 Europe Endometriosis Treatment Market, by Route of Administration, 2023 - 2023 (USD Billion)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific Endometriosis Treatment Market, 2023 - 2023 (USD Billion)
- 8.5.3.1 Asia Pacific Endometriosis Treatment Market, by Country, 2023 - 2023 (USD Billion)
- 8.5.3 Asia Pacific Endometriosis Treatment Market, 2023 - 2023 (USD Billion)
- 8.4 Asia Pacific Endometriosis Treatment Market, by Drug Class, 2023 - 2023
- 8.4.1 Asia Pacific Endometriosis Treatment Market, by Drug Class, 2023 - 2023 (USD Billion)
- 8.5 Asia Pacific Endometriosis Treatment Market, by Treatment Type, 2023 - 2023
- 8.5.1 Asia Pacific Endometriosis Treatment Market, by Treatment Type, 2023 - 2023 (USD Billion)
- 8.6 Asia Pacific Endometriosis Treatment Market, by Route of Administration, 2023 - 2023
- 8.6.1 Asia Pacific Endometriosis Treatment Market, by Route of Administration, 2023 - 2023 (USD Billion)
- 8.6. Latin America
- 8.6.4 Latin America Endometriosis Treatment Market, 2023 - 2023 (USD Billion)
- 8.6.4.1 Latin America Endometriosis Treatment Market, by Country, 2023 - 2023 (USD Billion)
- 8.6.4 Latin America Endometriosis Treatment Market, 2023 - 2023 (USD Billion)
- 8.4 Latin America Endometriosis Treatment Market, by Drug Class, 2023 - 2023
- 8.4.1 Latin America Endometriosis Treatment Market, by Drug Class, 2023 - 2023 (USD Billion)
- 8.5 Latin America Endometriosis Treatment Market, by Treatment Type, 2023 - 2023
- 8.5.1 Latin America Endometriosis Treatment Market, by Treatment Type, 2023 - 2023 (USD Billion)
- 8.6 Latin America Endometriosis Treatment Market, by Route of Administration, 2023 - 2023
- 8.6.1 Latin America Endometriosis Treatment Market, by Route of Administration, 2023 - 2023 (USD Billion)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa Endometriosis Treatment Market, 2023 - 2023 (USD Billion)
- 8.7.5.1 The Middle-East and Africa Endometriosis Treatment Market, by Country, 2023 - 2023 (USD Billion)
- 8.7.5 The Middle-East and Africa Endometriosis Treatment Market, 2023 - 2023 (USD Billion)
- 8.4 The Middle-East and Africa Endometriosis Treatment Market, by Drug Class, 2023 - 2023
- 8.4.1 The Middle-East and Africa Endometriosis Treatment Market, by Drug Class, 2023 - 2023 (USD Billion)
- 8.5 The Middle-East and Africa Endometriosis Treatment Market, by Treatment Type, 2023 - 2023
- 8.5.1 The Middle-East and Africa Endometriosis Treatment Market, by Treatment Type, 2023 - 2023 (USD Billion)
- 8.6 The Middle-East and Africa Endometriosis Treatment Market, by Route of Administration, 2023 - 2023
- 8.6.1 The Middle-East and Africa Endometriosis Treatment Market, by Route of Administration, 2023 - 2023 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Bayer AG
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 AbbVie Inc.
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Johnson & Johnson
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 AstraZeneca plc
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Pfizer Inc.
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Roche Holding AG
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Gedeon Richter Plc
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Myovant Sciences Ltd.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Neurocrine Biosciences Inc.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Astellas Pharma Inc.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Sanofi S.A.
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Takeda Pharmaceutical Co. Ltd.
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Kissei Pharmaceutical Co. Ltd.
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Eli Lilly and Company
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Repros Therapeutics Inc.
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Ferring Pharmaceuticals Inc.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Anika Therapeutics Inc.
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Merck & Co. Inc.
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Meditrina Pharmaceuticals Inc.
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.1 Bayer AG
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Endometriosis Treatment Market, 2023 - 2023 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Endometriosis Treatment Market attractiveness, By Drug Class
- 6. Global Endometriosis Treatment Market attractiveness, By Treatment Type
- 7. Global Endometriosis Treatment Market attractiveness, By Route of Administration
- 8. Global Endometriosis Treatment Market share by Drug Class, 2023 and 2023 (USD Billion)
- 9. Global Endometriosis Treatment Market by Oral Contraceptive, 2023 - 2023 (USD Billion)
- 10. Global Endometriosis Treatment Market by NSAIDs, 2023 - 2023 (USD Billion)
- 11. Global Endometriosis Treatment Market by Gonadotropin Releasing Hormones, 2023 - 2023 (USD Billion)
- 12. Global Endometriosis Treatment Market by Others, 2023 - 2023 (USD Billion)
- 13. Global Endometriosis Treatment Market share by Treatment Type, 2023 and 2023 (USD Billion)
- 14. Global Endometriosis Treatment Market by Hormone Therapy, 2023 - 2023 (USD Billion)
- 15. Global Endometriosis Treatment Market by Pain Medication, 2023 - 2023 (USD Billion)
- 16. Global Endometriosis Treatment Market share by Route of Administration, 2023 and 2023 (USD Billion)
- 17. Global Endometriosis Treatment Market by Injectable, 2023 - 2023 (USD Billion)
- 18. Global Endometriosis Treatment Market by Oral, 2023 - 2023 (USD Billion)
- 19. Global Endometriosis Treatment Market by Others, 2023 - 2023 (USD Billion)
- 20. Global Endometriosis Treatment Market share, by Region, 2023 and 2023
- 21. North America Endometriosis Treatment Market, 2023 - 2023 (USD Billion)
- 22. Europe Endometriosis Treatment Market, 2023 - 2023 (USD Billion)
- 23. Asia Pacific Endometriosis Treatment Market, 2023 - 2023 (USD Billion)
- 24. Latin America Endometriosis Treatment Market, 2023 - 2023 (USD Billion)
- 25. The Middle-East and Africa Endometriosis Treatment Market, 2023 - 2023 (USD Billion)
Table Of Tables
- 1. Global Endometriosis Treatment Market: Snapshot
- 2. Drivers of the Endometriosis Treatment Market: impact analysis
- 3. North America Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 4. North America Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 5. North America Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 6. U.S. Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 7. U.S. Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 8. U.S. Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 9. Canada Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 10. Canada Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 11. Canada Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 12. Europe Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 13. Europe Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 14. Europe Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 15. Germany Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 16. Germany Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 17. Germany Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 18. France Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 19. France Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 20. France Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 21. U.K. Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 22. U.K. Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 23. U.K. Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 24. Italy Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 25. Italy Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 26. Italy Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 27. Spain Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 28. Spain Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 29. Spain Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 30. Rest of Europe Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 31. Rest of Europe Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 32. Rest of Europe Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 33. Asia Pacific Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 34. Asia Pacific Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 35. Asia Pacific Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 36. China Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 37. China Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 38. China Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 39. Japan Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 40. Japan Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 41. Japan Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 42. India Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 43. India Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 44. India Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 45. South Korea Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 46. South Korea Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 47. South Korea Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 48. South-East Asia Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 49. South-East Asia Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 50. South-East Asia Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 51. Rest of Asia Pacific Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 52. Rest of Asia Pacific Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 53. Rest of Asia Pacific Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 54. Latin America Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 55. Latin America Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 56. Latin America Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 57. Brazil Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 58. Brazil Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 59. Brazil Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 60. Mexico Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 61. Mexico Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 62. Mexico Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 63. Rest of Latin America Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 64. Rest of Latin America Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 65. Rest of Latin America Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 66. The Middle-East and Africa Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 67. The Middle-East and Africa Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 68. The Middle-East and Africa Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 69. GCC Countries Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 70. GCC Countries Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 71. GCC Countries Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 72. South Africa Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 73. South Africa Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 74. South Africa Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
- 75. Rest of Middle-East Africa Endometriosis Treatment Market revenue, By Drug Class, 2023 - 2023 (USD Billion)
- 76. Rest of Middle-East Africa Endometriosis Treatment Market revenue, By Treatment Type, 2023 - 2023 (USD Billion)
- 77. Rest of Middle-East Africa Endometriosis Treatment Market revenue, By Route of Administration, 2023 - 2023 (USD Billion)
Methodology
FrequentlyAsked Questions
Endometriosis is a medical condition that impacts the female segment of the population. Endometrial tissue typically acts as the lining for the uterus which is a female reproductive organ.
The global endometriosis treatment market is projected to grow owing to the rising prevalence of the condition.
According to study, the global endometriosis treatment market size was worth around USD 1.3 billion in 2022 and is predicted to grow to around USD 3.2 billion by 2030.
The CAGR value of endometriosis treatment market is expected to be around 13.51% during 2023-2030.
The global endometriosis treatment market is projected to register the highest growth in North America.
The global endometriosis treatment market is led by players like Bayer AG, AbbVie Inc., Johnson & Johnson, AstraZeneca plc, Pfizer Inc., Roche Holding AG, Gedeon Richter Plc, Myovant Sciences Ltd., Neurocrine Biosciences, Inc., Astellas Pharma Inc., Sanofi S.A., Takeda Pharmaceutical Co. Ltd., Kissei Pharmaceutical Co., Ltd., Eli Lilly and Company, Repros Therapeutics Inc., Ferring Pharmaceuticals Inc., Anika Therapeutics, Inc., Merck & Co., Inc., and Meditrina Pharmaceuticals, Inc.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed